The type of HT reported before the age of 18 is known as the juvenile variant
However, all these treatments are symptomatic and cannot prevent or reverse AD pathology ( Figure 1 ) ( Figure 1 Biological characteristics of GLP-1 In the 1980s, a new glucagon-like peptide, produced from proglucagon cleavage, was discovered to stimulate insulin secretion ( GLP-1, a 36-amino acid peptide, is produced in enteroendocrine L-cells of the distal small bowel and colon ( The effect of GLP-1 depends on blood glucose levels since it can only potentiate glucose-stimulated insulin secretion from islet beta cells in the hyperglycemic state rather than in the normal blood glucose state (98101)
The effect isn't instant, and it's not a substitute for adequate protein or sunscreen, but it can be a useful layer of support
Recent Food and Drug Administration warnings also point to a need for increased public awareness of potential harm
The most commonly reported adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, rather than neurological pain syndromes
